Navigation Links
Solazyme, Inc. Selected by AlwaysOn as a GoingGreen 100 Top Private Company Award Winner
Date:9/11/2007

Recognized for Leadership in Clean Technology and Global Business Potential

SOUTH SAN FRANCISCO, Calif., Sept. 11 /PRNewswire/ -- Solazyme, Inc., a leading algal biotechnology company, today announced that it has been selected by AlwaysOn as one of the GoingGreen 100 Top Private Companies for 2007. The first-annual elite GoingGreen 100 list was compiled by the AlwaysOn editorial panel. In order to be eligible for the GoingGreen 100 list, companies had to be peer-nominated, with AlwaysOn receiving more than 500 nominations from venture investors, investment bankers and other industry experts.

"The AlwaysOn GoingGreen 100 companies will accelerate the global movement to a more sustainable environment," said Tony Perkins, founder and editor of AlwaysOn. "The ideas and innovation we saw as we reviewed hundreds of clean technology companies will be foundational to the next wave of economic growth in California and beyond. My congratulations to each AlwaysOn GoingGreen 100 winner -- these are the companies which we predict will have the greatest market traction, strongest innovation and most game-changing approaches this year."

Solazyme and the GoingGreen 100 Top Private Companies for 2007 will be honored at AlwaysOn GoingGreen to be held at the University of California in Davis from September 10 -- 12. GoingGreen is a two-and-a-half-day executive gathering that highlights the significant impact clean technologies have on new economic growth and in sustainable use of natural resources. The idea behind the GoingGreen 100 top private companies list is to identify the most promising entrepreneurial opportunities and investments in the clean technology industry.

Solazyme is a leading biotechnology company focused on the engineering and optimization of algae for production of biofuels and health and wellness materials. Solazyme has developed algal strains with dramatically increased biofuel and industrial chemical production capabilities. This novel technology results in large reductions in CO2 and other pollutants over traditional fossil fuels.

"We are pleased to be recognized for our development of fuels and industrial chemicals from renewable resources. Our focus on algal biotechnology will enable rapid development and deployment of facilities capable of producing commercial scale quantities of biodiesel," said Jonathan Wolfson, President of Solazyme. Harrison Dillon, CEO of Solazyme, added "The use of renewable resources for production of biofuels that are compatible with the existing transportation fuel infrastructure and that meet existing fuel standards is crucially important for rapid large scale adoption. We are excited to make a major contribution to reducing our dependency on imported oil and creating new employment opportunities for Americans."

A full list of all the AlwaysOn GoingGreen 100 Private Companies can be found on the AlwaysOn Web site at: http://alwayson.goingon.com/permalink/post/18632

About AlwaysOn GoingGreen: AlwaysOn GoingGreen is a two-and-a-half-day executive gathering that highlights the significant impact clean technologies have on new economic growth and in sustainable use of natural resources. AlwaysOn GoingGreen features the most innovative companies, eminent technologists, influential investors and journalists in keynote presentations, panel debates and private company CEO showcases. The goal of the conference is to identify the most promising entrepreneurial opportunities and investments in the clean tech industry.

About Solazyme:

Founded in 2003 and headquartered in South San Francisco, California, Solazyme is a leading biotechnology company focused on the engineering and optimization of algae for production of biofuels and health and wellness materials. For more information, please visit our website: http://www.solazyme.com.

About AlwaysOn

AlwaysOn ignited the open-media revolution in early 2003 by being the first media brand to launch a global blog network. In 2004, AlwaysOn continued to lead the media industry in innovation by introducing a social network where members can connect and engage. AlwaysOn is also revolutionizing the media business by applying its open-media principles to its executive event series (Stanford Summit, AlwaysOn Hollywood, AlwaysOn Media and GoingGreen) and quarterly print "blogozine" by empowering its members to post and share their ideas and meet each other online. As our loyal readers know, AlwaysOn is committed to the free-market, merit-driven approach to reporting and event programming. No other media brand has dared to create such open interaction with its readers and event participants.

For Solazyme For AlwaysOn Going Green

Walter Rakitsky A&R Edelman

Ph: 650-780-4777 Kimberly Kupiecki

wrakitsky@solazyme.com Ph: 650-533-4049

kkupiecki@ar-edelman.com


'/>"/>
SOURCE Solazyme, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. San Diego firm selected for Madison Wi-Fi project
2. Milwaukee-based eFilm software selected by InSight Health, announces Workstation upgrade
3. Berbee Selected by Microsoft as Featured Speaker for New Product Launch
4. In pursuit of capital, be sure to track your private offering
5. When raising capital, why use a Private Placement Memorandum?
6. Of private equity, research, and drug development
7. Third Wave Technologies to raise $14.9M through private debt
8. Computer recycling: An environmental mandate the private sector can support
9. With patents and research tools, when is private really public?
10. Platypus raises $1.2 million from private investors
11. Wisconsin private college group picks Jenzabar for common IT platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS ... the addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US ... absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... analysis platform specifically designed for life science researchers to analyze and interpret ... Rosalind Franklin, who made a major contribution to the discovery of the ...
(Date:10/11/2017)... ... 11, 2017 , ... The CRISPR-Cas9 system has ... and avoiding the use of exogenous expression plasmids. The simplicity of programming this ... gain-of-function studies. , This complement to loss-of-function studies, such as with RNAi ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back ... 8th June 2018 in San Francisco, CA. The Summit brings together current and former ... CEOs, board directors and government officials from around the world to address key issues ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
Breaking Biology News(10 mins):